Static Chart Lytix Biopharma

Equities

Real-time Oslo Bors Other stock markets 15:45:00 22/05/2024 BST			5-day change	1st Jan Change
5.4 ^NOK	0.00%		-14.01%	+11.11%

04-25	Lytix Biopharma Announces Approval of the Phase II Study in Early-Stage Skin Cancer Representing A Significant Commercial Opportunity	CI
04-10	Lytix Biopharma to Raise Up to NOK55 Million via Share Offering	MT

Duration

Period